Department of Neurological Surgery, Hospital del Niño "Dr. Ovidio Aliaga Uria", La Paz, Bolivia.
Department of Neurological Surgery, University of Miami, Jackson Memorial Hospital, Miami, FL, USA.
J Neurooncol. 2024 Jun;168(2):275-282. doi: 10.1007/s11060-024-04664-9. Epub 2024 Apr 2.
How pediatric medulloblastoma patients fare in Lower Middle-Income Country (LMICs) in South America is not well understood. Correspondingly, the aim of this study was to summarize the pediatric neurosurgical experience of an institution in La Paz, and compare outcomes to that of a generalized High Income Country (HIC) United States (US) experience.
A retrospective review of all pediatric neurosurgical medulloblastoma patients at the Children's Hospital of La Paz, Bolivia (Hospital del Niño "Dr. Ovidio Aliaga Uria") between 2014 and 2023 was conducted and compared to a generalized US experience abstracted from the US National Cancer Database (NCDB) and National Inpatient Sample (NIS) databases. Categorical, continuous and survival data were statistically summarized and compared.
A total of 24 pediatric medulloblastoma patients underwent neurosurgical treatment at the Hospital del Niño. In this La Paz cohort, there were 15 (63%) males and 9 (38%) females, with a mean age of 5.6 years old at diagnosis. The majority of patients underwent subtotal resection (STR, 79%), while the remaining patients underwent biopsy only. Ten (42%) patients expired during their hospitalization, and mean length of stay overall was 39 days. Only 8 (33%) patients received adjuvant treatment after surgery. Median overall survival from diagnosis in the La Paz cohort was 1.9 months. Compared to the US databases, the La Paz cohort experienced significantly more emergency room admissions for surgery, less gross total resection, more STR, more return to operating room for ventriculoperitoneal shunting, more bacteremia, more tracheostomy procedures, more percutaneous gastrostomy placements, longer lengths of stay, less adjuvant chemotherapy, less radiation therapy, shorter follow-up, and ultimately, significantly shorter overall survival (all P < 0.050).
Pediatric neurosurgical medulloblastoma outcomes at the Children's Hospital of La Paz, Bolivia are significantly inferior to that of a generalized US experience. Future research is required to identify institution- and country-specific initiatives to improve discrepancies between institutions in LMICs in South America compared to HICs.
南美的中低收入国家(LMICs)中,小儿髓母细胞瘤患者的预后情况尚不清楚。因此,本研究旨在总结玻利维亚拉巴斯儿童医院(“Ovidio Aliaga Uria 儿童医院”)的小儿神经外科髓母细胞瘤患者的经验,并将其结果与美国(US)的一般高收入国家(HIC)经验进行比较。
对 2014 年至 2023 年期间在玻利维亚拉巴斯儿童医院(“Ovidio Aliaga Uria 儿童医院”)接受神经外科治疗的所有小儿髓母细胞瘤患者进行回顾性研究,并与美国国家癌症数据库(NCDB)和国家住院患者样本(NIS)数据库中提取的一般美国经验进行比较。对分类、连续和生存数据进行了统计学总结和比较。
共有 24 名小儿髓母细胞瘤患者在“Ovidio Aliaga Uria 儿童医院”接受神经外科治疗。在拉巴斯队列中,有 15 名(63%)男性和 9 名(38%)女性,诊断时的平均年龄为 5.6 岁。大多数患者接受了次全切除术(STR,79%),而其余患者仅接受了活检。10 名(42%)患者在住院期间死亡,总住院时间平均为 39 天。仅有 8 名(33%)患者在手术后接受了辅助治疗。拉巴斯队列的中位总生存期从诊断开始为 1.9 个月。与美国数据库相比,拉巴斯队列接受手术的急诊就诊明显更多,大体全切除明显更少,STR 更多,脑室-腹腔分流术的再手术更多,菌血症更多,气管切开术更多,经皮胃造口术更多,住院时间更长,辅助化疗更少,放疗更少,随访时间更短,最终总生存期明显更短(所有 P<0.050)。
玻利维亚拉巴斯儿童医院的小儿神经外科髓母细胞瘤预后明显差于美国的一般经验。需要进一步研究,以确定机构和国家特定的举措,以缩小南美的中低收入国家与高收入国家之间机构之间的差距。